Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is a progressive neurodegenerative disorder for which numerous mouse models have been generated. In both AD patients and mouse models, there is increasing evidence that neuronal dysfunction occurs before the accumulation of β-amyloid (Aβ)-containing plaques and neurodegeneration. Characterization of the timing and nature of preplaque dysfunction is important for understanding the progression of this disease and to identify pathways and molecular targets for therapeutic intervention. Hence, we have examined the progression of dysfunction at the morphological, functional, and behavioral levels in the Tg2576 mouse model of AD. Our data show that decreased dendritic spine density, impaired long-term potentiation (LTP), and behavioral deficits occurred months before plaque deposition, which was first detectable at 18 months of age. We detected a decrease in spine density in the outer molecular layer of the dentate gyrus (DG) beginning as early as 4 months of age. Furthermore, by 5 months, there was a decline in LTP in the DG after perforant path stimulation and impairment in contextual fear conditioning. Moreover, an increase in the Aβ42/Aβ40 ratio was first observed at these early ages. However, total amyloid levels did not significantly increase until ≈18 months of age, at which time significant increases in reactive astrocytes and microglia could be observed. Overall, these data show that the perforant path input from the entorhinal cortex to the DG is compromised both structurally and functionally, and this pathology is manifested in memory defects long before significant plaque deposition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Whereas high-frequency stimulation significantly increased the magnitude of long-term potentiation (LTP) at Schaffer collateral (SC)-CA1 synapses in the hippocampus of wild type (WT) mice, LTP was significantly impaired in 6-to 7-mo-old APP/PS1 mice (17,18).”
From IL-33 ameliorates Alzheimer's disease-like pathology and cognitive decline (2016) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This is different from the progression in Tg2576, which manifests synaptic damage at an early stage of pathological development (4.5 months) [68,69] with a corresponding decrease in synaptic density markers [70] prior to Aβ plaque development (10 months) [71] and cognitive deficiencies (one year) [72,73].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [69]
The cited source says what the claim attributes to it.
In the citing paper
“Tg2576 mice began to show impaired LTP and synaptic transmission in dentate gyrus (DG) at 4–5 mo or older (Jacobsen et al., 2006).”
From VPS35 haploinsufficiency increases Alzheimer’s disease neuropathology (2011) · cites this paper as Jacobsen et al., 2006
In the citing paper
“The widely used Tg2576 mouse model expresses mutant human APP and displays decreased spine density in the CA1 and dentate gyrus, well before the development of amyloid plaques, further evidence that soluble Aβ oligomers initiate at least some Alzheimer’s disease–related pathology68,95.”
From Dendritic spine pathology in neuropsychiatric disorders (2011) · cites this paper as [95]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Natural oligomers of the amyloid-β protein specifically disrupt cognitive function
Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2005) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,687
Life and Death of Neurons in the Aging Brain
Morrison, J. H., & Hof, P. R. (1997) · Science · doi:10.1126/science.278.5337.412 · Cited by 1,344
Self-citationDeciphering the Molecular Basis of Memory Failure in Alzheimer's Disease
Walsh, D. M., & Selkoe, D. J. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.010 · Cited by 1,207
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Cited by
Items 201–300 of 789
Goshen, I., Avital, A., Kreisel, T., Licht, T., Segal, M., & Yirmiya, R. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5352-08.2009 · Cited by 82
“Furthermore, TG2576 mice (which constitute a model for Alzheimer’s disease) demonstrate a concomitant decrease in spine density, LTP, and fear conditioning before A deposition (Jacobsen et al., 2006).”
BackgroundCordella, A., Krashia, P., Nobili, A., Pignataro, A., La Barbera, L., Viscomi, M. T., Valzania, A., Keller, F., Ammassari-Teule, M., Mercuri, N. B., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.05.006 · Cited by 82
Imbimbo, B. P., Giardino, L., Sivilia, S., Giuliani, A., Gusciglio, M., Pietrini, V., Del Giudice, E., D'Arrigo, A., Leon, A., Villetti, G., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1366 · Cited by 75
Carvedilol as a potential novel agent for the treatment of Alzheimer's disease
Wang, J., Ono, K., Dickstein, D. L., Arrieta-Cruz, I., Zhao, W., Qian, X., Lamparello, A., Subnani, R., Ferruzzi, M., Pavlides, C., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.004 · Cited by 73
Ciccone, R., Franco, C., Piccialli, I., Boscia, F., Casamassa, A., de Rosa, V., Cepparulo, P., Cataldi, M., Annunziato, L., & Pannaccione, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-50018-1 · Cited by 74
Chen, S.-Q., Wang, P.-J., Ten, G.-J., Zhan, W., Li, M.-H., & Zang, F.-C. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000261646 · Cited by 76
Arshavsky, Y. I. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.09.004 · Cited by 81
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79
“However, these Tg2576 mice show impaired performance in a hippocampal- dependent contextual fear-conditioning assay, low spine density in the dentate gyrus and impairment of LTP long before the first detection of Ab dodecamers (Jacobsen et al. 2006).”
Chronic lithium treatment magnifies learning in rats
Nocjar, C., Hammonds, M. D., & Shim, S. S. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.063 · Cited by 79
Role of Tau Protein in Neuronal Damage in Alzheimer's Disease and Down Syndrome
Cárdenas, A. M., Ardiles, Á. O., Barraza, N., Báez‐Matus, X., & Caviedes, P. A. (2012) · Archives of Medical Research · doi:10.1016/j.arcmed.2012.10.012 · Cited by 81
Altered synapses in a Drosophila model of Alzheimer's disease
Mhatre, S. D., Satyasi, V., Killen, M., Paddock, B. E., Moir, R. D., Saunders, A. J., & Marenda, D. R. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.012104 · Cited by 79
Peng, C., Hu, J., Liu, D., Hong, X., Wu, Y., Zhu, L., & Wang, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.12.010 · Cited by 79
Mann, A. P., Scodeller, P., Hussain, S., Braun, G. B., Mölder, T., Toome, K., Ambasudhan, R., Teesalu, T., Lipton, S. A., & Ruoslahti, E. I. (2017) · Nature Communications · doi:10.1038/s41467-017-01096-0 · Cited by 79
Pasinetti, G. M. (2012) · Planta Medica · doi:10.1055/s-0032-1315377 · Cited by 80
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases: An Overview
Bem, A. F. D., Krolow, R., Farias, H. R., de Rezende, V. L., Gelain, D. P., Moreira, J. C. F., Duarte, J. M. N., & de Oliveira, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.604150 · Cited by 79
Gao, L., Tian, M., Zhao, H., Xu, Q., Huang, Y., Si, Q., Tian, Q., Wu, Q., Hu, X., Sun, L., et al. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13432 · Cited by 77
Amyloid and Alzheimer's Disease: Inside and Out
Tam, J. H. K., & Pasternak, S. H. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100013408 · Cited by 66
Low‐n oligomers as therapeutic targets of Alzheimer’s disease
Ono, K., & Yamada, M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07187.x · Cited by 76
Wurtman, R. J., Cansev, M., Sakamoto, T., & Ulus, I. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00344.x · Cited by 66
Increased Hippocampal Excitability in the 3xTgAD Mouse Model for Alzheimer's Disease In Vivo
Davis, K. E., Fox, S., & Gigg, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091203 · Cited by 73
The functional neurophysiology of the amyloid precursor protein (APP) processing pathway
Randall, A. D., Witton, J., Booth, C., Hynes-Allen, A. M., & Brown, J. T. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.011 · Cited by 77
Choi, D., & Choi, H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0503-5 · Cited by 77
Pahnke, J., Walker, L. C., Scheffler, K., & Krohn, M. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.05.006 · Cited by 66
Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
McDaid, J., Mustaly-Kalimi, S., & Stutzmann, G. E. (2020) · Cells · doi:10.3390/cells9122655 · Cited by 73
Changes in adult neurogenesis in neurodegenerative diseases: cause or consequence?
Thompson, A., Boekhoorn, K., Van Dam, A. ‐., & Lucassen, P. J. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2007.00379.x · Cited by 73
Modeling Alzheimer’s disease: from past to future
Saraceno, C., Musardo, S., Marcello, E. E., Pelucchi, S., & Luca, M. D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00077 · Cited by 75
Price, K. A., Varghese, M., Sowa, A., Yuk, F., Brautigam, H., Ehrlich, M. E., & Dickstein, D. L. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-41 · Cited by 65
APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD)
Lalonde, R., Fukuchi, K., & Strazielle, C. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.011 · Cited by 62
Errico, F., Nisticò, R., Napolitano, F., Oliva, A., Romano, R., Barbieri, F., Florio, T., Russo, C., Mercuri, N. B., & Usiello, A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.007 · Cited by 72
Detecting spatial memory deficits beyond blindness in tg2576 Alzheimer mice
Yassine, N., Lazaris, A., Dorner‐Ciossek, C., Després, O., Meyer, L., Maître, M., Mensah‐Nyagan, A. G., Cassel, J., & Mathis, C. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.016 · Cited by 71
Tabuchi, M., Yamaguchi, T., Iizuka, S., Imamura, S., Ikarashi, Y., & Kase, Y. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.12.010 · Cited by 72
Fuentealba, R. A., Barría, M. I., Lee, J., Cam, J., Araya, C., Escudero, C. A., Inestrosa, N. C., Bronfman, F. C., Bu, G., & Marzolo, M.-P. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-14 · Cited by 70
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
Sciaccaluga, M., Megaro, A., Bellomo, G., Ruffolo, G., Romoli, M., Palma, E., & Costa, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115991 · Cited by 70
Tamagnini, F., Scullion, S., Brown, J. T., & Randall, A. D. (2014) · Hippocampus · doi:10.1002/hipo.22403 · Cited by 70
Gene expression parallels synaptic excitability and plasticity changes in Alzheimer’s disease
Saura, C. A., Parra-Damas, A., & Enriquez-Barreto, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00318 · Cited by 65
Childhood and adolescent obesity and long‐term cognitive consequences during aging
Wang, J., Freire, D., Knable, L. A., Zhao, W., Gong, B., Mazzola, P., Ho, L., Levine, S., & Pasinetti, G. M. (2014) · The Journal of Comparative Neurology · doi:10.1002/cne.23708 · Cited by 70
Nisticò, R., Ferraina, C., Marconi, V., Blandini, F., Negri, L., Egebjerg, J., & Feligioni, M. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00063 · Cited by 59
Electronic Terahertz Antennas and Probes for Spectroscopic Detection and Diagnostics
Grade, J. D., Haydon, P. G., & van der Weide, D. W. (2007) · Proceedings of the IEEE · doi:10.1109/jproc.2007.898900 · Cited by 70
Bramham, C. R. (2007) · Progress in Brain Research · doi:10.1016/s0079-6123(07)63025-8 · Cited by 69
Mishra, R., Phan, T., Kumar, P., Morrissey, Z. D., Gupta, M., Hollands, C., Shetti, A., Lopez, K. L., Maienschein‐Cline, M., Suh, H., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20220391 · Cited by 70
Ageing and protein aggregation-mediated disorders: from invertebrates to mammals
Dillin, A. G., & Cohen, E. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0271 · Cited by 69
Understanding the molecular basis of Alzheimer’s disease using a Caenorhabditis elegans model system
Ewald, C. Y., & Li, C. (2009) · Brain Structure and Function · doi:10.1007/s00429-009-0235-3 · Cited by 71
Pourbadie, H. G., Sayyah, M., Khoshkholgh-Sima, B., Choopani, S., Nategh, M., Motamedi, F., & Shokrgozar, M. A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.020 · Cited by 68
Chaalal, A., Poirier, R., Blum, D., Gillet, B., Leblanc-Veyrac, P., Basquin, M., Buée, L., Laroche, S., & Enderlin, V. (2014) · Hippocampus · doi:10.1002/hipo.22319 · Cited by 68
Shen, Y., Tian, M., Zheng, Y., Gong, F., Fu, A. K. Y., & Ip, N. Y. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.043 · Cited by 67
Imaging Synaptic Density: The Next Holy Grail of Neuroscience?
Serrano, M. E., Kim, E., Petrinovic, M. M., Turkheimer, F., & Cash, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.796129 · Cited by 67
Lawlor, P. A., Bland, R. J., Das, P., Price, R. W., Holloway, V., Smithson, L., Dicker, B. L., During, M. J., Young, D., & Golde, T. E. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-11 · Cited by 67
“Indeed, in Tg2576 mice the appearance of behavioral deficits is associated with the initial occurrence of insoluble Aβ accumulation at a time when no overt plaque formation is noted [9,42-48].”
BackgroundResultAndrouin, A., Potier, B., Nägerl, U. V., Cattaert, D., Danglot, L., Thierry, M., Youssef, I., Triller, A., Duyckaerts, C. J., Hachimi, K. H. E., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1847-6 · Cited by 67
Auffret, A., Gautheron, V., Repici, M., Kraftsik, R., Mount, H. T. J., Mariani, J., & Rovira, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1856-09.2009 · Cited by 62
Caluwé, J. D., & Dupont, G. (2013) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2013.04.015 · Cited by 70
Xu, Y., Chen, P., Wang, X., Yao, J., & Zhuang, S. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.01.045 · Cited by 67
Nicotinic Acetylcholine Receptor Signaling in Neuroprotection
Akaike, A., Shimohama, S., & Misu, Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-8488-1 · Cited by 67
Ribarič, S. (2023) · Biomedicines · doi:10.3390/biomedicines11020355 · Cited by 66
Khan, M. M., Wakade, C. G., Sevilla, L. M. D., & Brann, D. W. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.05.001 · Cited by 66
β-Amyloid 42/40 ratio and kalirin expression in Alzheimer disease with psychosis
Murray, P. S., Kirkwood, C. M., Gray, M. C., Ikonomovic, M. D., Paljug, W. R., Abrahamson, E. E., Henteleff, R. A., Hamilton, R. L., Kofler, J. K., Klunk, W. E., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.02.015 · Cited by 54
Baglietto‐Vargas, D., Prieto, G. A., Limon, A., Forner, S., Rodriguez‐Ortiz, C. J., Ikemura, K., Ager, R. R., Medeiros, R., Trujillo‐Estrada, L., Martini, A. C., et al. (2018) · Aging Cell · doi:10.1111/acel.12791 · Cited by 65
Lalande, J., Halley, H., Balayssac, S., Gilard, V., Déjean, S., Martino, R., Francés, B., Lassalle, J.-M., & Malet-Martino, M. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-130023 · Cited by 58
Wilcock, D. M., Zhao, Q., Morgan, D., Gordon, M. N., Everhart, A., Wilson, J. G., Lee, J. E., & Colton, C. A. (2011) · ASN Neuro · doi:10.1042/an20110018 · Cited by 58
Hu, M., Schurdak, M. E., Puttfarcken, P. S., Kouhen, R. E., Gopalakrishnan, M., & Li, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.051 · Cited by 65
Schmid, A. W., Lynch, M. A., & Herron, C. E. (2009) · Hippocampus · doi:10.1002/hipo.20542 · Cited by 64
Lindhagen‐Persson, M., Brännström, K., Vestling, M., Steinitz, M. O., & Olofsson, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013928 · Cited by 64
Optogenetics and its application in neural degeneration and regeneration
Xu, X., Ordaz, J. D., & Wu, W. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.213532 · Cited by 65
Auffret, A., Gautheron, V., Mattson, M. P., Mariani, J., & Rovira, C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1302 · Cited by 64
Daulatzai, M. A. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1404-6 · Cited by 63
Zhang, Y., Kurup, P., Xu, J., Anderson, G. M., Greengard, P., Nairn, A. C., & Lombroso, P. J. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07450.x · Cited by 55
Phivilay, A., Julien, C., Tremblay, C., Berthiaume, L., Julien, P., Giguère, Y., & Calon, F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.12.006 · Cited by 65
Kervern, M., Angeli, A., Nicole, O., Léveillé, F., Parent, B., Villette, V., Buisson, A., & Dutar, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120394 · Cited by 63
Balducci, C., Mehdawy, B., Mare, L., Giuliani, A., Lorenzini, L., Sivilia, S., Giardino, L., Calzà, L., Lanzillotta, A., Sarnico, I., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101839 · Cited by 62
Disrupted-In-Schizophrenia-1 (DISC1) interactome and mental disorders: Impact of mouse models
Lipina, T. V., & Roder, J. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.001 · Cited by 63
Progressive impairment in olfactory working memory in a mouse model of Mild Cognitive Impairment
Young, J. W., Sharkey, J., & Finlayson, K. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.018 · Cited by 62
Briggs, D. I., Defensor, E., Memar Ardestani, P., Yi, B., Halpain, M., Seabrook, G., & Shamloo, M. (2017) · eneuro · doi:10.1523/eneuro.0025-17.2017 · Cited by 61
“In vivo, APPSwe Tg mice displayed behavioral impairments, including locomotor hyperactivity and learning and memory deficits (Hsiao et al., 1996; Jacobsen et al., 2006).”
BackgroundEarly-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease
Willuweit, A., Velden, J., Godemann, R., Manook, A., Jetzek, F., Tintrup, H., Kauselmann, G., Zevnik, B., Henriksen, G., Drzezga, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007931 · Cited by 61
Porrini, V., Lanzillotta, A., Branca, C., Benarese, M., Parrella, E., Lorenzini, L., Calzà, L., Flaibani, R., Spano, P., Imbimbo, B. P., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.10.029 · Cited by 60
Wang, Y., Tang, X. C., & Zhang, H. (2011) · Journal of Neuroscience Research · doi:10.1002/jnr.22775 · Cited by 61
A New Player in the “Synaptopathy” of Alzheimer’s Disease – Arc/Arg 3.1
Kerrigan, T. L., & Randall, A. D. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00009 · Cited by 60
Decreased drebrin mRNA expression in Alzheimer disease: Correlation with tau pathology
Julien, C., Tremblay, C., Bendjelloul, F., Phivilay, A., Coulombe, M., Émond, V., & Calon, F. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21667 · Cited by 48
Peroxiredoxin II preserves cognitive function against age-linked hippocampal oxidative damage
Kim, S., Jin, M.-H., Kim, Y. S., Lee, S., Cho, Y. S., Cho, K.-J., Lee, K., Kim, Y. I., Kim, G. W., Kim, J., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.05.017 · Cited by 61
18F-FDG-PET in Mouse Models of Alzheimer's Disease
Bouter, C., & Bouter, Y. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00071 · Cited by 59
Bai, Y., Li, M., Zhou, Y., Ma, L., Qiao, Q., Hu, W., Li, W., Wills, Z. P., & Gan, W.-B. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0228-2 · Cited by 56
Biphasic cortical macro‐ and microstructural changes in autosomal dominant Alzheimer's disease
Montal, V., Vilaplana, E., Pegueroles, J., Bejanin, A., Alcolea, D., Carmona‐Iragui, M., Clarimón, J., Levin, J., Cruchaga, C., Graff‐Radford, N. R., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12224 · Cited by 55
Rózga, M., & Bal, W. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900358j · Cited by 58
Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model
McMillan, L. E., Brown, J. T., Henley, J. M., & Cimarosti, H. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.07.045 · Cited by 58
Deng, X., Ai, W., Lei, D., Luo, X. G., Yan, X.-X., & Li, Z. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.022 · Cited by 60
Hermann, D., Both, M., Ebert, U., Gross, G., Schoemaker, H., Draguhn, A., Wicke, K. M., & Nimmrich, V. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.044 · Cited by 57
A circuit view of deep brain stimulation in Alzheimer’s disease and the possible mechanisms
Yu, D., Yan, H., Zhou, J., Yang, X., Lu, Y., & Han, Y. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0334-4 · Cited by 58
Wu, X., Liu, C., Chen, L., Du, Y.-F., Hu, M., Reed, M. N., Long, Y., Suppiramaniam, V., Hong, H., & Tang, S.-S. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.03.065 · Cited by 56
Penazzi, L., Tackenberg, C., Ghori, A., Golovyashkina, N., Niewidok, B., Selle, K., Ballatore, C., Smith, A. B., Bakota, L., & Brandt, R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.002 · Cited by 51
Shahidi, ., Asl, S. S., Komaki, A., & Hashemi-Firouzi, N. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4862-3 · Cited by 55
Panikker, P., Xu, S., Zhang, H., Sarthi, J. B., Beaver, M., Sheth, A., Akhter, S., & Elefant, F. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.2840-17.2018 · Cited by 55
Generic inhibition of amyloidogenic proteins by two naphthoquinone–tryptophan hybrid molecules
Scherzer‐Attali, R., Shaltiel‐Karyo, R., Adalist, Y. H., Segal, D., & Gazit, E. (2012) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24080 · Cited by 55
Ohno, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.04.007 · Cited by 55
Capsaicin Attenuates Amyloid-β-Induced Synapse Loss and Cognitive Impairments in Mice
Chen, L., Huang, Z., Du, Y., Fu, M., Han, H., Wang, Y., & Dong, Z. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-170337 · Cited by 54
“Decreases in the density of dendritic spines and alterations in their morphology, which are related to learning and memory decline, occur in AD patient [2, 43–45] and in animals models of AD [46, 47].”
Kerrigan, T. L., Brown, J. T., & Randall, A. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.004 · Cited by 48
Origlia, N., Capsoni, S., Cattaneo, A., Fang, F., Arancio, O., Yan, S. D., & Domenici, L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1045 · Cited by 54
The reemergence of long-term potentiation in aged Alzheimer’s disease mouse model
Huh, S., Baek, S.-J., Lee, K.-H., Whitcomb, D. J., Jo, J., Choi, S.-M., Kim, D. H., Park, M.-S., Lee, K. H., & Kim, B. C. (2016) · Scientific Reports · doi:10.1038/srep29152 · Cited by 49
Entorhinal cortical defects in Tg2576 mice are present as early as 2–4 months of age
Duffy, Á. M., Morales-Corraliza, J., Bermudez-Hernandez, K. M., Schaner, M. J., Magagna-Poveda, A., Mathews, P. M., & Scharfman, H. E. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.001 · Cited by 52
Das, S. R., Avants, B. B., Pluta, J., Wang, H., Suh, J. W., Weiner, M. W., Mueller, S. G., & Yushkevich, P. A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.098 · Cited by 47
Vugmeyster, Y., Szklut, P., Wensel, D. L., Ross, J. E., Xu, X., Awwad, M., Gill, D. S., Tchistiakov, L., & Warner, G. L. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0405-x · Cited by 52
Selective Degeneration of Entorhinal-CA1 Synapses in Alzheimer's Disease via Activation of DAPK1
Shu, S., Zhu, H., Tang, N., Chen, W., Li, X., Li, H., Pei, L., Liu, D., Mu, Y., Tian, Q., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.2258-16.2016 · Cited by 51
Sharman, M. J., Gyengési, E., Liang, H., Chatterjee, P., Karl, T., Li, Q.-X., Wenk, M. R., Halliwell, B. B., Martins, R. N., & Münch, G. W. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.11.026 · Cited by 52
Metadata
- Authors
- Jacobsen, J. S., Wu, C.-C., Redwine, J. M., Comery, T. A., Arias, R., Bowlby, M., Martone, R., Morrison, J. H., Pangalos, M. N., Reinhart, P. H., & Bloom, F. E.
- Affiliations
- Wyeth (US)
- Neurome, Inc., La Jolla, CA 92037; and
- Icahn School of Medicine at Mount Sinai (US)
- Scripps Research Institute (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-03-20
- Volume
- 103
- Issue
- 13
- Pages
- 5161-5166
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1405622
- OpenAlex
- W2136901555
- Cited by
- 701
- References
- 44
- Citations by year
- 2026: 17 · 2025: 16 · 2024: 26 · 2023: 31 · 2022: 24 · 2021: 32 · 2020: 26 · 2019: 32 · 2018: 35 · 2017: 28 · 2016: 42 · 2015: 26 · 2014: 40 · 2013: 35 · 2012: 46
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, dendritic spine density, long-term potentiation, dentate gyrus, perforant path, contextual fear conditioning, memory impairment, amyloid-beta 42/40 ratio, amyloid plaques, reactive astrocytes, microglia, entorhinal cortex
- MeSH terms
- Aging, Alzheimer Disease, Animals, Behavior, Animal, Brain, Disease Models, Animal, Fear, Memory, Mice, Transgenic, Organ Size, Spine, Synapses, Time Factors, Amyloid beta-Peptides, Synaptophysin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.